BioNTech (BNTX) Short Interest Ratio & Short Volume → 1970’s computer coder Issues Shocking AI Warning (From InvestorPlace) (Ad) Free BNTX Stock Alerts $92.74 +2.61 (+2.90%) (As of 12:26 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media BioNTech Short Interest DataCurrent Short Volume3,160,000 sharesPrevious Short Volume3,080,000 sharesChange Vs. Previous Month+2.60%Dollar Volume Sold Short$277.73 millionShort Interest Ratio / Days to Cover5.0Last Record DateApril 15, 2024Outstanding Shares237,730,000 sharesFloat Size237,710,000 sharesShort Percent of Float1.33%Today's Trading Volume331,067 sharesAverage Trading Volume650,381 sharesToday's Volume Vs. Average51% Short Selling BioNTech ? Sign up to receive the latest short interest report for BioNTech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBNTX Short Interest Over TimeBNTX Days to Cover Over TimeBNTX Percentage of Float Shorted Over Time Ad American Hartford Gold GroupRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE BioNTech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,160,000 shares $277.73 million +2.6%1.3%5 $87.89 3/31/20243,080,000 shares $284.13 million No Change1.3%4.7 $92.25 3/15/20243,080,000 shares $284.84 million +5.5%1.3%4.5 $92.48 2/29/20242,920,000 shares $259.76 million -3.0%1.2%4.1 $88.96 2/15/20243,010,000 shares $279.66 million -0.3%1.3%4.3 $92.91 1/31/20243,020,000 shares $287.02 million -5.3%1.3%4.4 $95.04 Get the Latest News and Ratings for BNTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioNTech and its competitors with MarketBeat's FREE daily newsletter. 1/15/20243,190,000 shares $330.39 million +16.0%1.3%4.3 $103.57 12/31/20232,750,000 shares $290.24 million -20.1%1.2%3.8 $105.54 12/15/20233,440,000 shares $351.57 million +14.3%1.5%4.8 $102.20 11/30/20233,010,000 shares $302.23 million +13.2%1.3%4.6 $100.41 11/15/20232,660,000 shares $267.89 million -18.4%1.1%4.2 $100.71 10/31/20233,260,000 shares $304.94 million +38.1%N/A4.5 $93.54 10/15/20232,360,000 shares $244.45 million -8.9%N/A3.1 $103.58 9/30/20232,590,000 shares $281.38 million -6.5%N/A3.8 $108.64 9/15/20232,770,000 shares $313.18 million +13.5%N/A4.2 $113.06 8/31/20232,440,000 shares $295.07 million +15.6%N/A3.5 $120.93 8/15/20232,110,000 shares $223.03 million +18.5%N/A2.9 $105.70 7/31/20231,780,000 shares $193.79 million -1.1%N/A2.4 $108.87 7/15/20231,800,000 shares $194.83 million -9.1%N/A2.6 $108.24 6/30/20231,980,000 shares $213.70 million -15.0%N/A2.9 $107.93 6/15/20232,330,000 shares $263.29 million +14.8%N/A3.3 $113.00 5/31/20232,030,000 shares $213.31 million +0.5%N/A2.9 $105.08 5/15/20232,020,000 shares $217.96 million +5.2%N/A2.9 $107.90 4/30/20231,920,000 shares $219.34 million -5.0%N/A3 $114.24 4/15/20232,020,000 shares $261.91 million +6.9%N/A3.3 $129.66 3/31/20231,890,000 shares $235.44 million +5.6%N/A2.9 $124.57 3/15/20231,790,000 shares $232.59 million -8.7%N/A2.6 $129.94 2/28/20231,960,000 shares $254.90 million +32.4%N/A2.5 $130.05 2/15/20231,480,000 shares $218.48 million -23.7%N/A1.8 $147.62 1/31/20231,940,000 shares $278.22 million +23.6%N/A2.2 $143.41 1/15/20231,570,000 shares $227.73 million +7.5%N/A1.6 $145.05 12/30/20221,460,000 shares $219.32 million +4.3%N/A1.5 $150.22 12/15/20221,400,000 shares $254.86 million -15.7%N/A1.5 $182.04 11/30/20221,660,000 shares $277.25 million -11.7%N/A1.8 $167.02 11/15/20221,880,000 shares $307.81 million -12.2%N/A2.2 $163.73 10/31/20222,140,000 shares $294.55 million -3.2%N/A2.5 $137.64 10/15/20222,210,000 shares $299.72 million -32.0%N/A2.5 $135.62 9/30/20223,250,000 shares $438.36 million +12.9%N/A3.8 $134.88 9/15/20222,880,000 shares $415.12 million +56.5%N/A3 $144.14 8/31/20221,840,000 shares $266.14 million -5.2%N/A1.8 $144.641970’s computer coder Issues Shocking AI Warning (Ad)Louis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP BNTX Short Interest - Frequently Asked Questions What is BioNTech's current short interest? Short interest is the volume of BioNTech shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 3,160,000 shares of BNTX short. 1.33% of BioNTech's shares are currently sold short. Learn More on BioNTech's current short interest. What is a good short interest ratio for BioNTech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNTX shares currently have a short interest ratio of 5.0. Learn More on BioNTech's short interest ratio. Which institutional investors are shorting BioNTech? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioNTech: Concourse Financial Group Securities Inc., Simplex Trading LLC, IMC Chicago LLC, and UBS Group AG. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for BioNTech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.33% of BioNTech's floating shares are currently sold short. Is BioNTech's short interest increasing or decreasing? BioNTech saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 3,160,000 shares, an increase of 2.6% from the previous total of 3,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BioNTech's float size? BioNTech currently has issued a total of 237,730,000 shares. Some of BioNTech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioNTech currently has a public float of 237,710,000 shares. How does BioNTech's short interest compare to its competitors? 1.33% of BioNTech's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to BioNTech: argenx SE (2.24%), Neurocrine Biosciences, Inc. (2.01%), Bio-Techne Co. (3.66%), Biogen Inc. (2.26%), Qiagen (1.34%), Repligen Co. (8.85%), Vaxcyte, Inc. (7.60%), Revolution Medicines, Inc. (7.33%), Exelixis, Inc. (3.01%), ImmunityBio, Inc. (40.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short BioNTech stock? Short selling BNTX is an investing strategy that aims to generate trading profit from BioNTech as its price is falling. BNTX shares are trading down $0.75 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioNTech? A short squeeze for BioNTech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BNTX, which in turn drives the price of the stock up even further. How often is BioNTech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNTX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ARGX Short Interest NBIX Short Interest TECH Short Interest BIIB Short Interest QGEN Short Interest RGEN Short Interest PCVX Short Interest RVMD Short Interest EXEL Short Interest IBRX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BNTX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith348 million Americans lives to END as we know it?The Oxford ClubUrgent Nvidia WarningAltimetryThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders